Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection.
Malden DE, Liu IA, Qian L, Sy LS, Lewin BJ, Asamura DT, Ryan DS, Bezi C, Williams JTB, Kaiser R, Daley MF, Nelson JC, McClure DL, Zerbo O, Henninger ML, Fuller CC, Weintraub ES, Saydah S, Tartof SY. Malden DE, et al. Among authors: mcclure dl. Nat Commun. 2024 May 22;15(1):4101. doi: 10.1038/s41467-024-48022-9. Nat Commun. 2024. PMID: 38778026 Free PMC article.
Mortality risk after COVID-19 vaccination: A self-controlled case series study.
Xu S, Sy LS, Hong V, Farrington P, Glenn SC, Ryan DS, Shirley AM, Lewin BJ, Tseng HF, Vazquez-Benitez G, Glanz JM, Fireman B, McClure DL, Hurley LP, Yu O, Wernecke M, Smith N, Weintraub ES, Qian L. Xu S, et al. Among authors: mcclure dl. Vaccine. 2024 Mar 7;42(7):1731-1737. doi: 10.1016/j.vaccine.2024.02.032. Epub 2024 Feb 22. Vaccine. 2024. PMID: 38388239 Free article.
Long-term Neutralizing Antibody Levels Against Measles and Rubella Viruses Among Adults With 3 Doses of Measles-Mumps-Rubella Vaccine.
Alonge OD, Marin M, Hickman CJ, Sowers SB, Chen MH, Hao L, Mercader S, El-Badry E, McClure DL, Icenogle JP, Sugerman DE, Crooke SN, Nguyen HQ. Alonge OD, et al. Among authors: mcclure dl. Open Forum Infect Dis. 2024 Jan 3;11(1):ofad700. doi: 10.1093/ofid/ofad700. eCollection 2024 Jan. Open Forum Infect Dis. 2024. PMID: 38213634 Free PMC article.
Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink.
Katherine Yih W, Daley MF, Duffy J, Fireman B, McClure DL, Nelson JC, Qian L, Smith N, Vazquez-Benitez G, Weintraub E, Williams JTB, Xu S, Maro JC. Katherine Yih W, et al. Among authors: mcclure dl. Vaccine. 2023 Aug 14;41(36):5265-5270. doi: 10.1016/j.vaccine.2023.07.010. Epub 2023 Jul 20. Vaccine. 2023. PMID: 37479610
Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022.
Petrie JG, King JP, McClure DL, Rolfes MA, Meece JK, Pattinson D, Neumann G, Kawaoka Y, Belongia EA, McLean HQ. Petrie JG, et al. Among authors: mcclure dl. Influenza Other Respir Viruses. 2023 Mar 1;17(3):e13104. doi: 10.1111/irv.13104. eCollection 2023 Mar. Influenza Other Respir Viruses. 2023. PMID: 36875208 Free PMC article.
A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination.
Xu S, Huang R, Sy LS, Hong V, Glenn SC, Ryan DS, Morrissette K, Vazquez-Benitez G, Glanz JM, Klein NP, Fireman B, McClure D, Liles EG, Weintraub ES, Tseng HF, Qian L. Xu S, et al. Among authors: mcclure d. Vaccine. 2023 Jan 16;41(3):844-854. doi: 10.1016/j.vaccine.2022.12.036. Epub 2022 Dec 20. Vaccine. 2023. PMID: 36564276 Free PMC article.
310 results